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Drug reaction with eosinophilia and systemic
symptoms (DRESS), or drug-induced hypersensitiv-
ity syndrome, is a severe adverse drug reaction
characterized by cutaneous eruption, fever, leuko-
cytosis with eosinophilia or atypical lymphocytosis,
lymphadenopathy, and liver or other internal organ
involvement.1 DRESS typically presents 2 to 12weeks
after drug exposure.2 Common causative agents
include anticonvulsants, allopurinol, antibiotics,
and nonsteroidal anti-inflammatory drugs. An asso-
ciation with reactivation of human herpes virus 6 and
other herpesviruses has also been found.3 Various
long-term outcomes after resolution of DRESS have
been reported, few of which are autoimmune
sequelae such as autoimmune thyroiditis, scleroder-
moid graft-versus-host diseaseelike skin lesions, and
systemic lupus erythematosus.1 Nonautoimmune,
fulminant type 1 diabetes mellitus (T1DM), a subtype
characterized by rapid onset with absence of
diabetes-related autoantibodies, has been reported
as a sequela of DRESS.1 In contrast, cases of classic
autoimmune T1DM have rarely been presented.
Here, we report a case of classic autoimmune
T1DM in a patient after resolution of DRESS.CASE REPORT
A 44-year-old Vietnamese man with history of
hypertension, congestive heart failure, and predia-
betes presented for a rash involving the face, chest,
and back. He recently returned from a 2-month stay
in Vietnam, and a rash developed 1 week beforeDepartment of Dermatology, University of California,
chool of Medicine.
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CA 92697. E-mail: jshiu1@uci.edu.presentation. After taking hydroxyzine, diphenhy-
dramine, and steroids prescribed at an outside hos-
pital, he had facial swelling, rash extending to
extremities and genitals, worsening of pruritus, and
scaling with sloughing including mucous mem-
branes. He had stopped taking his prescribed
antihypertensive medications for 3 to 4 months and
denied taking herbal medications. He reported
taking an unspecified antibiotic and pain medica-
tions for unclear reasons for several days while in
Vietnam a month before presentation. On physical
examination, he was afebrile but mildly tachycardic
with diffuse confluent erythematous macules on his
trunk, palms, upper and lower extremities (Fig 1),
and fissuring and hemorrhagic crust on mucosal lips
with superficial tongue erosions. Facial edema,
increased eye lacrimation, mild conjunctival injec-
tion, and cervical lymphadenopathy were noted.
There were no pustules, bullae, or Nikolsky sign.
Laboratory findings were notable for leukocytosis
(18600) and eosinophilia (19%), and liver (peak
aspartate aminotransferase, 103 U/L; alanine amino-
transferase, 276 U/L) and renal dysfunctionJAAD Case Reports 2018;4:295-7.
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Fig 1. Diffuse confluent erythematous macules of lower
extremities.
Fig 2. Microscopic examination of skin biopsies shows
infiltration of lymphocytes in the dermoepidermal junction
with apoptotic keratinocytes, parakeratosis, extravasated
erythrocytes, and rare dermal eosinophils. (Hematoxylin-
eosin stain; original magnification: 3200.)
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59 mg/dL). Skin biopsies on the left clavicle and
left forearm found infiltration of lymphocytes in
the dermoepidermal junction with apoptotic kerati-
nocytes, parakeratosis, extravasated erythrocytes,
and rare dermal eosinophils (Fig 2). Examination
and laboratory findings were consistent with DRESS
according to the RegiSCAR criteria. Our patient
was started on prednisone, 80 mg/d; triamcinolone
0.1% ointment twice a day; and Vaseline 3 times a
day. He was discharged 6 days later on prednisone,
60 mg/d after liver, kidney, and hematologic
abnormalities normalized.
Unfortunately, our patient re-presented 9 days
later with altered mental status and was admitted for
diabetic ketoacidosis with hyperglycemia. Low
C-peptide (0.3 ng/mL; normal, 0.9 to 7.1) and
glutamic acid decarboxylase (GAD) antibodies
(27.1 IU/mL; normal, \5.0) confirmed type 1
diabetes mellitus (T1DM) and indicated an
autoimmune pathogenesis. He was monitored
closely and provided diabetes education. Because
of T1DM, he required a daily regimen of insulin on
discharge. He was also discharged on prednisone,
40 mg/d, tapered slowly over 2 months.
DISCUSSION
DRESS is a potentially life-threatening drug reac-
tion characterized by delayed onset, multiorgan
involvement, and autoimmune sequelae.1
Pathogenesis of DRESS is not well understood and
depends on genetic background, drug metabolism,
and virus reactivation. Post-DRESS autoimmune
pathogenesis manifestations have not been well
defined, but T-regulatory (Treg) cells are believed
to play a role by suppressing immune system
activation, maintaining self-antigen tolerance, and
preventing autoimmune diseases.4 During DRESS
resolution, despite being present in normal
numbers, Treg cells lose their suppressive ability to
inhibit cytokine production and proliferation ofeffector T cells, contributing to subsequent autoim-
mune development.
Several studies on sequelae of DRESS have found
autoimmune development.1,5-7 Rarely reported
T1DM cases are predominantly nonautoimmune
fulminant type, characterized by rapid onset with
absence of islet-related GAD antibodies and near
complete destruction of pancreatic b cells, and
developing 2 weeks to 10 months after DRESS
onset.1 Chen et al5 found 1 of 43 patients who had
fulminant T1DM 48 days after DRESS. Kano et al6
reported 5 of 145 patients who had fulminant T1DM
within 2 months after DRESS. Chiou et al2 reported 2
of 30 patients who had T1DM of unspecified sub-
type, 2 and 10 months after DRESS.
In contrast, classic autoimmune T1DM with
detection of various autoantibodies including IA2
and anti-GAD is reported less frequently. To date, 3
cases of autoimmune T1DM have been reported
(Table I). Ozaki et al8 reported on a 50-year-old man
with autoimmune T1DM (GAD antibody 24.1U/mL)
diagnosed 4 months after DRESS. Brown et al9
reported on a 15-year-old girl with autoimmune
T1DM (elevated GAD, unspecified) and Graves dis-
ease 7 months and 5 months, respectively, after
DRESS.9 Lan et al10 reported on a 13-year-old girl
with autoimmune T1DM (GAD antibody 2 U/mL)
development 6 months after DRESS. Our case
represents the fourth case of classic autoimmune
T1DM after DRESS.
Our case is distinct from previous cases of
autoimmune T1DM with earlier onset of 3 weeks
after DRESS, compared with 4 to 7 months in other
studies. In our case, an unknown antibiotic that our
patient took abroad was thought to be the culprit
medication. The cause of autoimmune T1DM was
unclear in our patient but presumably involved
Table I. Reported cases of autoimmune type 1 diabetes mellitus after DRESS/drug-induced hypersensitivity
syndrome
Reference Age (y)/gender/race Culprit drug
Time to T1DM
development Relevant T1DM values Other sequelae
2006
Ozaki et al.8
50/male/
Japanese
Methimazole 4 mo C-peptide, 0.35 ng/mL;
GAD antibody, 24.1 U/mL
None
2009
Brown et al.9
15/female/— Minocycline 7 mo Unspecified elevated
GAD antibody level,
detected IA2 antibody titer,
HLA DRB1-DQA1-DQB1
haplotypes
Autoimmune thyroiditis,
Graves disease; elevated
ANA, anti-Smith, and
anti-SS-A/Ro antibody titers
2016
Lan et al.10
13/female/— Minocycline 6 mo GAD antibody 2 U/mL,
negative islet cell antibody
Positive antithyroid peroxidase
and antithyroglobulin
antibodies
ANA, Antinuclear antibodies; HLA, human leukocyte antigen.
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lution. Given that T1DM frequently presents as initial
diabetic ketoacidosis, it is vital to monitor patients for
7 months or longer after DRESS resolution for early
detection and intervention of this and other autoim-
mune sequelae. Future studies differentiating ge-
netic associations, viral reactivation, and causative
drugs in fulminant and autoimmune diabetes will
help elucidate a mechanism of development and
identify at-risk patients who require long-termmoni-
toring of autoimmune markers after DRESS.
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